Theta Burst Stimulation in Pharmacologically Untreated Patients as Sole Antidepressant Treatment
This study is active but not recruiting. It focuses on depression and currently lists study information in Germany.
Key information made simple
This study is looking at whether intermittend theta burst stimulation (iTBS) can help people with Depression. Participants receive a study treatment and complete follow-up visits and assessments. Taking part may give some people access to intermittend theta burst stimulation (iTBS), but direct benefit is not guaranteed.
Your next step
The official record suggests in-person participation through a research setting, with sites including Department of Psychiatry and Psychotherapy in Regensburg. Participation appears to involve a study treatment together with follow-up visits and routine safety or progress checks. The main fit is usually meeting the main study requirements, while common reasons not to take part include major medical issues that could make participation unsuitable and pregnancy or breastfeeding. The official record does not list a formal phase, which usually means this is focused more on feasibility, delivery, or support than a standard drug-development stage.
Questions to ask before joining
- What are the exact eligibility criteria, and what could exclude someone?
- How many visits, assessments, or follow-ups are expected, and over what period?
- What risks, side effects, practical burdens, or alternatives should be understood first?
- Who should be contacted to confirm locations, timing, compensation, and next steps?
Things to check before joining
- Recruitment status
- Active Not Recruiting
- Estimated enrollment
- Not clearly listed
- Sponsor
- University of Regensburg
- Sponsor type
- University
- Study type
- Device
- Intervention type
- Device / app / digital / technology
- Study phase
- Not clearly listed
- Locations
- Germany
- Age range
- From 18 Years to 70 Years
- Official registry ID
- NCT05732298
- Official source
- Official registry link
Want help reviewing this study?
Key study information
- Official title
- Theta Burst Stimulation in Pharmacologically Untreated Patients as Sole Antidepressant Treatment
- Condition
- Depression
- Study status
- Active Not Recruiting
- Sponsor / lead affiliation
- University of Regensburg
- Location / country
- Germany
- Registry
- ClinicalTrials.gov
- External trial ID
- NCT05732298
Why this study may matter
This study may matter because it adds public evidence around depression. HopeStage presents it as a starting point for understanding the study, checking the official source, and preparing questions with a care team.
For you
Taking part may give access to a new approach being evaluated.
It requires regular visits and structured follow-up.
Requires travel, with in-person participation in Germany.
Not medical advice
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
Questions about this study
What is this study trying to understand?
This study is exploring brain stimulation for people with depression. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
Does this study involve a device, app, or technology?
This appears to be a device / app / digital / technology study. The phase is not clearly listed in the public registry. Phase is mostly relevant for medication studies and some device studies. For this study, it may be more useful to look at what is required, the duration, visits, and eligibility criteria.
Who might this study be for?
This study may concern people with depression; age range: From 18 Years to 70 Years. The criteria appear fairly specific, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
You may need to use a device, app, or digital tool for a defined period. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
What should I check about data, monitoring, alerts, and daily use?
If the study uses a device, app, or digital tool, check what data is collected, who can access it, how often you need to use it, and what happens if the tool detects a concerning signal. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by University of Regensburg, which appears to be a university. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The registry indicates that the study is active but not currently recruiting. This usually means participants may already be involved, but new participants may not be accepted.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me
